|
||
© The Rockefeller University Press,
0021-9525/1999//967 $5.00
The Journal of Cell Biology, Volume 146, Number 5,
, 1999 967-980
Original Article |
H-Ras Activation Promotes Cytoplasmic Accumulation and Phosphoinositide 3-Oh Kinase Association of β-Catenin in Epidermal Keratinocytes
acano{at}iib.uam.es
The mechanisms underlying downregulation of the cadherin/catenin complexes and β-catenin signaling during tumor progression are not fully understood. We have analyzed the effect of oncogenic H-Ras on E-cadherin/catenin complex formation/stabilization and β-catenin distribution in epidermal keratinocytes. Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and
-catenin and relocalization of β-catenin to the cytoplasm and nucleus. Moreover, these effects are dependent on PI3K (phosphoinositide 3-OH kinase) activity. Interestingly, a strong association of p85
and p110
subunits of PI3K with β-catenin is induced in V12Ras-expressing keratinocytes, and in vitro binding assays show a direct interaction between β-catenin and p85
. Overexpression of either V12Ras or constitutively active p110
induces metabolic stabilization of β-catenin and promotes its accumulation in cytoplasmic and nuclear pools. In addition, the interaction of β-catenin with the adenomatous polyposis coli protein is blocked in V12Ras and p110
transformants though no changes in glycogen synthase kinase 3 β activity could be detected. Nevertheless, in V12Ras transformants the in vivo phosphorylation of β-catenin in Ser residues is strongly decreased. These results indicate that H-Ras activation induces the relocalization and cytoplasmic stabilization of β-catenin by a mechanism involving its interaction with PI3K.
Key Words: H-Ras E-cadherin β-catenin adenomatous polyposis coli phosphoinositide 3-OH kinase
© 1999 The Rockefeller University Press
1.used in this paper: APC, adenomatous polyposis coli; GST, glutathione-S-transferase; GSK3β, glycogen synthase kinase 3β; H-Ras, Harvey-Ras; Lef-1/Tcf, lymphocyte enhancer factor 1/T cell factor; MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide 3-OH kinase; PP2A, protein phosphatase 2A
|
|